πŸ‡ΊπŸ‡Έ FDA
Patent

US 12391753

Antigen binding molecule formats

granted A61KA61K2039/505A61K39/395

Quick answer

US patent 12391753 (Antigen binding molecule formats) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K2039/505, A61K39/395, A61K47/6845, A61K47/6849